Therefore, the downregulation of Cyp8b1 in the ACLI model might trigger harmful consequences during liver disease progression, further increasing the known risk of HCC in Abcb4−/− mice [54]. This evidence concerns the gene CYP8B1 and hepatocellular carcinoma.